TYLENOL PM
- Product NDC
- 50580-833
- Requested package NDC
- 50580-833-01
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acetaminophen pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Sam's West Inc | cff9a730-2241-4e4c-bf6b-a2fa895e2417 | 2026-09-03 | Warnings | M013 |
| GOODYS MAX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 02b3a604-3f09-47e7-add1-b9038b3a268b | 2026-09-03 | Warnings | M013 |
| infants pain and fever | ACETAMINOPHEN | CVS Pharmacy | 53b06c48-598e-41ad-ac7a-5508c195535c | 2026-09-03 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | Cardinal Health 110, LLC. DBA Leader | 2777beea-06d7-4ff5-ae4a-ad7a117dfb62 | 2026-09-02 | Warnings | M013 |
| AMAZON BASIC CARE ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 113d92bf-f6c9-cc3d-e063-6294a90af033 | 2026-09-02 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | Shield Pharmaceuticals Corp. | 78052120-40d8-4a3f-b72f-cc78ca76213b | 2026-09-02 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | NuCare Pharmaceuticals,Inc. | fd199a7f-76ca-fefc-e053-6294a90a821d | 2026-09-02 | Warnings | M013 |
| Adult Low Dose Chewable Aspirin | ASPIRIN | Farmacias De Similares TX LLC | 513ea306-74c6-96e3-e063-6394a90a8262 | 2026-09-01 | Warnings | M013 |
| Kroger Children Pain plus Fever chewables | ACETAMINOPHEN | KROGER COMPANY | 83b5733c-70a1-4383-9729-2eb896d0149a | 2026-09-01 | Warnings | M013 |
| childrens acetaminophen | ACETAMINOPHEN | United Natural Foods, Inc. dba UNFI | f4642725-f953-4aa8-8106-f468d8220f65 | 2026-09-01 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | TOP CARE (Topco Associates LLC) | 923b443d-73cc-4c52-92e4-a075786b1ae3 | 2026-09-01 | Warnings | M013 |
| ACETAMINOPHEN PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Amazon.com Services LLC | 99a137d6-07eb-43bc-b4b4-1a23041d595e | 2026-08-31 | Warnings | M013 |
| MAX relief junior Grape | CHILDRENS ACETAMINOPHEN | Akron Pharma Inc. | cc769c26-556a-4831-bd75-61a7383aa707 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | CHILDRENS ACETAMINOPHEN | Akron Pharma Inc. | ebb3b4ba-2d0b-48d9-b6ee-6d4696aea047 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | ACETAMINOPHEN | Akron Pharma Inc. | 0e43b885-3843-4f11-9a53-02a38c228313 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | d7874e4d-0b38-4bb1-9a62-aa4f66d9baf9 | 2026-08-31 | Warnings | M013 |
| MAX relief junior Grape | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | 3c7a7f40-4963-4fd1-942e-93fa08a45830 | 2026-08-31 | Warnings | M013 |
| Genexa Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5a615118-33c9-1520-e063-6394a90a21a6 | 2026-08-31 | Warnings | M013 |
| acetaminophen extra strength | ACETAMINOPHEN | Sam's West Inc | dd99efd0-4ca4-4dc6-a940-bebd17ac8f8d | 2026-08-28 | Warnings | M013 |
| Medline | ACETAMINOPHEN | Medline Industries, LP | 4b0cc37c-56ce-6a73-e063-6394a90a80a3 | 2026-08-28 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |